225 related articles for article (PubMed ID: 19508730)
1. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
Dai SD; Wang Y; Miao Y; Zhao Y; Zhang Y; Jiang GY; Zhang PX; Yang ZQ; Wang EH
BMC Cancer; 2009 Jun; 9():178. PubMed ID: 19508730
[TBL] [Abstract][Full Text] [Related]
2. Kaiso is expressed in lung cancer: its expression and localization is affected by p120ctn.
Dai SD; Wang Y; Jiang GY; Zhang PX; Dong XJ; Wei Q; Xu HT; Li QC; Zhao C; Wang EH
Lung Cancer; 2010 Feb; 67(2):205-15. PubMed ID: 19615783
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of δ-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer.
Dai SD; Wang Y; Zhang JY; Zhang D; Zhang PX; Jiang GY; Han Y; Zhang S; Cui QZ; Wang EH
Cancer Sci; 2011 Jan; 102(1):95-103. PubMed ID: 21070476
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
Zhang S; Wang Y; Dai SD; Wang EH
BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
[TBL] [Abstract][Full Text] [Related]
5. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance.
Fan C; Zhao Y; Liu D; Zhang X; Wang E
Tumour Biol; 2011 Oct; 32(5):873-80. PubMed ID: 21603980
[TBL] [Abstract][Full Text] [Related]
6. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.
Miao Y; Wang L; Liu Y; Li AL; Liu SL; Cao HY; Zhang XP; Jiang GY; Liu D; Wang EH
Tumour Biol; 2013 Feb; 34(1):107-14. PubMed ID: 23001926
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
[TBL] [Abstract][Full Text] [Related]
9. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
[TBL] [Abstract][Full Text] [Related]
10. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
11. Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer.
Liu SL; Han Y; Zhang Y; Xie CY; Wang EH; Miao Y; Li HY; Xu HT; Dai SD
Target Oncol; 2012 Jun; 7(2):135-43. PubMed ID: 22585429
[TBL] [Abstract][Full Text] [Related]
12. delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm.
Zhang JY; Wang Y; Zhang D; Yang ZQ; Dong XJ; Jiang GY; Zhang PX; Dai SD; Dong QZ; Han Y; Zhang S; Cui QZ; Wang EH
J Pathol; 2010 Sep; 222(1):76-88. PubMed ID: 20593408
[TBL] [Abstract][Full Text] [Related]
13. ZCCHC9 promotes proliferation and invasion of lung cancer through regulating the JNK pathway.
Shi X; Jiang B; Liu H; Fan C
J Cell Biochem; 2019 Jun; 120(6):10596-10604. PubMed ID: 30644129
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
15. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
[TBL] [Abstract][Full Text] [Related]
16. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
17. Expression of a phosphorylated form of ATF4 in lung and non-small cell lung cancer tissues.
Fan CF; Miao Y; Lin XY; Zhang D; Wang EH
Tumour Biol; 2014 Jan; 35(1):765-71. PubMed ID: 23975372
[TBL] [Abstract][Full Text] [Related]
18. [Subcellular localization of survivin in non-small cell lung cancer].
He L; Hou M; Zhang J; Xu N; Chen P
Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
[TBL] [Abstract][Full Text] [Related]
19. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of cytoplasmic PLZF correlates with high tumor grade and tumor aggression in non-small cell lung carcinoma.
Xiao GQ; Li F; Findeis-Hosey J; Hyrien O; Unger PD; Xiao L; Dunne R; Kim ES; Yang Q; McMahon L; Burstein DE
Hum Pathol; 2015 Nov; 46(11):1607-15. PubMed ID: 26297253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
